Published: 17 February 2021
Author(s): Seamus P. Whelton, Philipp Berning, Roger S. Blumenthal, Catherine Handy Marshall, Seth S. Martin, Martin Bødtker Mortensen, Michael J. Blaha, Omar Dzaye
Issue: May 2021
Section: Review Article

Colorectal cancer (CRC) and Cardiovascular disease (CVD) represent leading causes of morbidity and mortality in industrialized countries [1]. While they are typically thought of as separate disease entities, there is growing evidence describing the shared pathophysiology between CRC and CVD [2–4]. Given the overlapping risk factor profile, combining preventive therapies for CRC and CVD along with optimizing acute oncologic treatment approaches to minimize CVD events represents a major opportunity to harmonize the management strategies of both diseases.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.